Press Releases
-
PDA Announces Early Career Professional Membership Type
The Parenteral Drug Association (PDA) today announced the availability of its newest membership type, the Early Career Professional. -
PDA Announces the Availability of ANSI/PDA Standard 05-2021 Consensus Method for Rating Filters for Mycoplasma
The Parenteral Drug Association (PDA) today announced the availability of industry standard, ANSI/PDA Standard 05-2021 Consensus Method for Rating Filters for Mycoplasma, available now for purchase in the PDA Bookstore. -
PDA Announces Availability of ANSI/PDA Standard 04-2021 Phage Retention Nomenclature Rating for Small and Large Virus-Retentive Filters
The Parenteral Drug Association (PDA) announced the availability of ANSI/PDA Standard 04-2021 Phage Retention Nomenclature Rating for Small and Large Virus-Retentive Filters. -
PDA to Collaborate with Deloitte and U.S. FDA to Improve the Quality of Compounded Drugs
Bethesda, Md. – The Parenteral Drug Association (PDA) today announced it has signed an agreement to collaborate with Deloitte Consulting, LLP and the U.S. FDA’s Compounding Quality Center of Excellence to provide training to large pharmaceutical compounders in a variety of Good Manufacturing Practices (GMP)-related functions critical to improving the overall quality of compound drugs.